PathogenDx Appoints Foremost Industry and Topic Experts as Its Advanced Microarray Testing Platform Sets New Standards in DNA-Based Testing Scottsdale, Arizona–(Newsfile Corp. – March 3, 2022) – PathogenDx, a U.S.-based biotechnology company, has bolstered its strategic advisory group and senior leadership team with the appointments of several highly experienced executives who will bring their expertise to the company as it sets a new global standard in molecular-based testing through the wides